文献速递造血干细胞移植与细胞治疗淋巴瘤

异基因HSCT后适应性NK与CMV特异性T细胞动态的单细胞分析

Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT.
PubMed 文献 · Blood Adv · 2026-01-01

该研究对32份供受者配对纵向血样行单细胞RNA与TCR测序至移植后3个月,并行pp65特异性T细胞测序。发现CMV血清学阳性供者受者适应性NK细胞成熟更快、回忆功能增强,而阴性供者细胞毒性更高;CD8+寡克隆扩增可占63.6%。

要点

  • 供者CMV血清学状态影响受者CMV再激活后免疫成熟速度与功能。
  • pp65NLV特异性CD8+寡克隆扩增最高达CD8+库的63.6%。
  • CMV再激活后NK与T细胞扩增前可见CD14+单核细胞早期增加。

核心结论

  • 供者CMV血清学状态影响CMV再激活受者的适应性免疫成熟时序与功能,可能有助于预测免疫重建时机。

研究设计与样本

  • 纵向队列研究,对供受者配对移植前后及移植后3个月共32份血样行单细胞RNA与TCR测序。
  • 另分选并TCR测序针对免疫优势CMV表位pp65的特异性T细胞。

主要发现

  • 移植后早期CD14+单核细胞增加,随后T与NK细胞扩增。
  • CD4+ T细胞组分中持续存在受者细胞嵌合。
  • CMV特异性T细胞与CMV相关适应性NK细胞在CMV血清学阴性供者中成熟较慢。
  • CMV血清学阳性供者受者适应性NK细胞早期成熟明显更快且回忆功能增强,但阴性供者受者适应性NK细胞细胞毒性更高。
  • 针对CMV pp65NLV表位的CD8+ T细胞大寡克隆扩增最高占CD8+ T细胞库的63.6%,呈终末成熟并上调经典NK细胞受体。

临床怎么用

  • 供者CMV血清学状态可用于预判CMV再激活受者免疫重建速度。
  • 监测适应性NK与pp65特异性CD8+ T细胞动态或有助于指导移植后并发症管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cytomegalovirus (CMV) reactivation reshapes immune reconstitution and remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). To understand the impact of asymptomatic CMV viremia on immune reconstitution, we profiled longitudinal blood samples (n = 32) from donor-recipient pairs before and after HSCT with single-cell RNA and T-cell receptor (TCR) sequencing for 3 months after transplantation. To analyze the development of antigen-specific T-cell responses in detail, we sorted and TCR-sequenced T cells specific to the immunodominant CMV epitope pp65. After HSCT, an early increase in CD14+ monocytes was observed, followed by expansion of T and natural killer (NK) cells. Persisting patient-cell chimerism was observed in the CD4+ T-cell fraction. CMV-specific T cells and CMV-associated adaptive NK cells matured slower in grafts from seronegative donors compared to those from seropositive donors. The early maturation of adaptive NK cells was markedly more rapid in patients with CMV-seropositive donors, with enhanced recall function; however, adaptive NK cell cytotoxicity was higher in patients with CMV-seronegative donors. Large oligoclonal CD8+ T-cell expansions against the immunodominant CMV pp65NLV epitope comprised up to 63.6% of the CD8+ T-cell repertoire, showing terminal maturation with upregulation of canonical NK cell receptors. Our study presents, to our knowledge, the first comprehensive single-cell transcriptomic characterization of adaptive immune recovery after allogeneic HSCT, with a particular focus on CMV reactivation. Our findings highlight the impact of donor CMV serostatus on immune maturation in recipients with CMV reactivation, which may help predict the timing of immune reconstitution and inform strategies for management of posttransplant complications.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Häkkinen AE, Huuhtanen J, Lundgren S, et al. Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT. Blood Adv. 2026. PMID: 42335212. doi:10.1182/bloodadvances.2026019733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。